Maky Zanganeh, Director at Pulse Biosciences, Inc. (PLSE), bought 13,000 shares at $11.97 ($156K) on 2017-02-15, disclosed to the SEC on 2017-02-22.
Open-market purchase of $156k PLSE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PLSE | BUY | 2020-06-25 | $13K | — | Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |